BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17668901)

  • 1. Immune mechanisms leading to abnormal B cell selection and activation in New Zealand Black mice.
    Roy V; Bonventi G; Cai Y; Macleod R; Wither JE
    Eur J Immunol; 2007 Sep; 37(9):2645-56. PubMed ID: 17668901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice.
    Loh C; Pau E; Chang NH; Wither JE
    Eur J Immunol; 2011 Feb; 41(2):527-36. PubMed ID: 21268021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice.
    Wither JE; Roy V; Brennan LA
    Clin Immunol; 2000 Jan; 94(1):51-63. PubMed ID: 10607490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
    Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
    Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of congenitally immunologic mutant New Zealand mice. II. Absence of T cell progenitor populations and B cell defects of congenitally athymic (nude) New Zealand Black (NZB) mice.
    Gershwin ME; Castles JJ; Erickson K; Ahmed A
    J Immunol; 1979 May; 122(5):2020-5. PubMed ID: 312856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation.
    Jyonouchi H; Kincade PW; Good RA; Gershwin ME
    J Immunol; 1983 Nov; 131(5):2219-25. PubMed ID: 6605377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic dissection of B cell traits in New Zealand black mice. The expanded population of B cells expressing up-regulated costimulatory molecules shows linkage to Nba2.
    Wither JE; Paterson AD; Vukusic B
    Eur J Immunol; 2000 Feb; 30(2):356-65. PubMed ID: 10671190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation.
    Pappu BP; Lin X
    Eur J Immunol; 2006 Nov; 36(11):3033-43. PubMed ID: 17048267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional absence of a B cell subpopulation in ageing New Zealand mice.
    Cohen PL
    Clin Exp Immunol; 1980 May; 40(2):365-72. PubMed ID: 7002389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
    Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
    Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of BCR density on the differentiation of natural poly-reactive B cells begins at an early stage of B cell development.
    Xing Y; Li W; Lin Y; Fu M; Li CX; Zhang P; Liang L; Wang G; Gao TW; Han H; Liu YF
    Mol Immunol; 2009 Mar; 46(6):1120-8. PubMed ID: 19136153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval.
    Wither JE; Loh C; Lajoie G; Heinrichs S; Cai YC; Bonventi G; MacLeod R
    J Immunol; 2005 Oct; 175(7):4309-19. PubMed ID: 16177071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-mediated suppression of nonspecific B cell activation. II. Relative resistance of B cells from the NZB mouse strain to regulation by a natural inhibitor in normal mouse serum.
    Walker SM; Sturtevant JE; Weigle WO
    J Immunol; 1981 Sep; 127(3):1204-7. PubMed ID: 6973581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immature B-cell subpopulation with low RAG1 expression is increased in the autoimmune New Zealand Black mouse.
    Toda T; Kitabatake M; Igarashi H; Sakaguchi N
    Eur J Immunol; 2009 Feb; 39(2):600-11. PubMed ID: 19180472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment and selection of marginal zone B cells is independent of exogenous antigens.
    Dammers PM; Kroese FG
    Eur J Immunol; 2005 Jul; 35(7):2089-99. PubMed ID: 15940667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells are selectively associated with thymic cortical but not medullary pathology in NZB mice.
    Taguchi N; Hashimoto Y; Hsu T; Ansari AA; Shultz L; Dorshkind K; Ikehara S; Naiki M; Gershwin ME
    J Autoimmun; 2001 Jun; 16(4):393-400. PubMed ID: 11437487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant IgM signaling promotes survival of transitional T1 B cells and prevents tolerance induction in lupus-prone New Zealand black mice.
    Roy V; Chang NH; Cai Y; Bonventi G; Wither J
    J Immunol; 2005 Dec; 175(11):7363-71. PubMed ID: 16301643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related alterations in the lymphohematopoietic and B-lineage precursor populations in NZB mice.
    Lian ZX; Okada T; Kita H; Hsu T; Shultz LD; Dorshkind K; Ansari AA; Naiki M; Ikehara S; Gershwin ME
    Stem Cells; 2002; 20(4):293-300. PubMed ID: 12110698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease.
    Jiang Y; Hirose S; Hamano Y; Kodera S; Tsurui H; Abe M; Terashima K; Ishikawa S; Shirai T
    J Immunol; 1997 Jan; 158(2):992-7. PubMed ID: 8993021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.